These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 18794567)

  • 1. Is patient cost-sharing the best way to protect the medical commons?
    Fletcher RH; Sabin JE; Dorsey J
    Ann Intern Med; 2008 Sep; 149(6):435; author reply 435-6. PubMed ID: 18794567
    [No Abstract]   [Full Text] [Related]  

  • 2. Divergent understanding of health professionals regarding correct subsequent management of an asymptomatic patient with a positive faecal occult blood test and negative colonoscopy with resultant cost implications.
    Beswick L; Ting A; Macrae F; Dowling D; Hair C
    Intern Med J; 2014 Dec; 44(12a):1264-5. PubMed ID: 25442767
    [No Abstract]   [Full Text] [Related]  

  • 3. Cost-effectiveness of colonoscopy in screening for colorectal cancer.
    Sonnenberg A; Delcò F; Inadomi JM
    Ann Intern Med; 2000 Oct; 133(8):573-84. PubMed ID: 11033584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of screening for colorectal cancer.
    Chelmowski MK
    Ann Intern Med; 2001 Aug; 135(3):218; author reply 219. PubMed ID: 11487491
    [No Abstract]   [Full Text] [Related]  

  • 5. Screening for colorectal cancer: which test can we afford?
    Lansdorp-Vogelaar I; van Ballegooijen M; Kuipers EJ
    Z Gastroenterol; 2008 Apr; 46 Suppl 1():S38-40. PubMed ID: 18368641
    [No Abstract]   [Full Text] [Related]  

  • 6. Screening for colon cancer--can we afford colonoscopy?
    Detsky AS
    N Engl J Med; 2001 Aug; 345(8):607-8. PubMed ID: 11529216
    [No Abstract]   [Full Text] [Related]  

  • 7. Expert panel offers advice to improve screening rates for colorectal cancer.
    Slomski A
    JAMA; 2010 Apr; 303(14):1356-7. PubMed ID: 20388886
    [No Abstract]   [Full Text] [Related]  

  • 8. Speaking for the evidence: colonoscopy vs computed tomographic colonography.
    Harris R
    J Natl Cancer Inst; 2010 Aug; 102(16):1212-4. PubMed ID: 20651321
    [No Abstract]   [Full Text] [Related]  

  • 9. Cancer screening before and after switching to a high-deductible health plan.
    Wharam JF; Galbraith AA; Kleinman KP; Soumerai SB; Ross-Degnan D; Landon BE
    Ann Intern Med; 2008 May; 148(9):647-55. PubMed ID: 18458277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Screening for colorectal cancer.
    Brown ML
    N Engl J Med; 1993 Oct; 329(18):1352-3. PubMed ID: 8292163
    [No Abstract]   [Full Text] [Related]  

  • 11. Cost-effectiveness modeling of colorectal cancer: computed tomography colonography vs colonoscopy or fecal occult blood tests.
    Lucidarme O; Cadi M; Berger G; Taieb J; Poynard T; Grenier P; Beresniak A
    Eur J Radiol; 2012 Jul; 81(7):1413-9. PubMed ID: 21444171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Waiving cost sharing for screening colonoscopy; free, but not clear.
    Dorn SD; Fendrick AM
    Clin Gastroenterol Hepatol; 2012 Jul; 10(7):767-8. PubMed ID: 22507879
    [No Abstract]   [Full Text] [Related]  

  • 13. Cost-effectiveness of mass screening for colorectal cancer: choice of fecal occult blood test and screening strategy.
    Sobhani I; Alzahouri K; Ghout I; Charles DJ; Durand-Zaleski I
    Dis Colon Rectum; 2011 Jul; 54(7):876-86. PubMed ID: 21654256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colorectal cancer screening.
    Hayee BH; Chung-Faye G
    Clin Med (Lond); 2006; 6(5):453-6. PubMed ID: 17080891
    [No Abstract]   [Full Text] [Related]  

  • 15. Cost-effectiveness of colorectal cancer screening with computed tomography colonography or fecal blood tests.
    Heresbach D; Chauvin P; Grolier J; Josselin JM
    Eur J Gastroenterol Hepatol; 2010 Nov; 22(11):1372-9. PubMed ID: 20802341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Arguments against implementing a population-based screening programme for colorectal cancer].
    Bonneux L
    Ned Tijdschr Geneeskd; 2008 Aug; 152(32):1777. PubMed ID: 18754310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy, effectiveness and cost-effectiveness of endoscopic screening methods.
    Brenner H
    Z Gastroenterol; 2008 Apr; 46 Suppl 1():S20-2. PubMed ID: 18368634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colorectal cancer screening and surveillance: the present and the future.
    Rex DK
    Rev Gastroenterol Disord; 2001; 1(1):18-31. PubMed ID: 12120116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methods and Economic Considerations: Group 1 Report. ESGE/UEGF Colorectal Cancer--Public Awareness Campaign. The Public/Professional Interface Workshop: Oslo, Norway, June 20 - 22, 2003. fulfillment corporate.
    Steele RJ; Gnauck R; Hrcka R; Kronborg O; Kuntz C; Moayyedi P; O'Morain C; Spicák J; Vainio H
    Endoscopy; 2004 Apr; 36(4):349-53. PubMed ID: 15057689
    [No Abstract]   [Full Text] [Related]  

  • 20. Colonoscopy with and without occult blood test pre-screening: which is more cost effective for implementation for screening for colon cancer?
    Wiwanitkit V
    Asian Pac J Cancer Prev; 2010; 11(3):823-4. PubMed ID: 21039061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.